{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:06:25Z","timestamp":1771603585595,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Type-1 Gaucher disease (GD1) is considered to be non- neuronopathic however recent evidence of neurological involvement continues to accumulate. There is limited evidence of retinal abnormalities in GD1. The purpose of this study was to evaluate the retinal findings of patients with GD1. Thirty GD1 individuals and 30 healthy volunteers between the ages 40\u201375 years were prospectively enrolled. Macular and optic nerve optical coherence tomography (OCT) scans of both eyes of each patient were performed and thickness maps were compared between groups. Patients with a known neurodegenerative disease, glaucoma, high myopia and previous intraocular surgeries were excluded. It was shown that patients with GD1 presented with higher incidence of abnormal pRNFL OCT scan and showed significantly thinner areas of pRNFL and macular ganglion cell complex (GCC) when compared to a healthy control population. Changes in retinal thickness were not associated with GD1 genotype, treatment status, disease monitoring biomarker (lyso-Gb1) and severity score index (Zimran SSI). Further investigations are needed to determine whether these findings possess functional visual implications and if retinal thinning may serve as biomarker for the development of future neurodegenerative disease in this population.<\/jats:p>","DOI":"10.3390\/ijms21197027","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:33:03Z","timestamp":1600936383000},"page":"7027","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4714-2594","authenticated-orcid":false,"given":"Yishay","family":"Weill","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"},{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0077-8608","authenticated-orcid":false,"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"},{"name":"Gaucher Unit, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zadok","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"},{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Wasser","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"},{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-0337","authenticated-orcid":false,"given":"Shoshana","family":"Revel-Vilk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"},{"name":"Gaucher Unit, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Hanhart","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"},{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tama","family":"Dinur","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"},{"name":"Gaucher Unit, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Arkadir","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"},{"name":"Department of Neurology, Hadassah Medical Center, Jerusalem 9112001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Becker-Cohen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Hebrew University, Jerusalem 9112001, Israel"},{"name":"Gaucher Unit, Shaare Zedek Medical Center, Jerusalem 9103102, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Prakash, G., and Iwata, T. (2017). Ocular Implications of Gaucher Disease. Advances in Vision Research, Volume I (Essentials in Ophthalmology), Springer.","DOI":"10.1007\/978-4-431-56511-6"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: A comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"key":"ref_3","unstructured":"Kaushansky, K., Lichtman, M.A., Prchal, J.T., Levi, M.M., Press, O.W., Burns, L.J., and Caligiuri, M. (2015). Gaucher Disease and Related Lysosomal Storage Diseases. Williams Hematology, McGrawHilll."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10545-010-9095-5","article-title":"The neurological manifestations of Gaucher disease type 1: The French Observatoire on Gaucher disease (FROG)","volume":"33","author":"Rose","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10545-012-9460-7","article-title":"The cognitive profile of type 1 Gaucher disease patients","volume":"35","author":"Biegstraaten","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jnnp.2006.111518","article-title":"Neurological evaluation of patients with Gaucher disease diagnosed as type 1","volume":"79","author":"Capablo","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Riboldi, G.M., and Di Fonzo, A.B. (2019). GBA, Gaucher Disease, and Parkinson\u2019s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells, 8.","DOI":"10.3390\/cells8040364"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM Int. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: Complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"ref_11","first-page":"1","article-title":"Patterns of retinal ganglion cell damage in neurodegenerative disorders: Parvocellular vs magnocellular degeneration in optical coherence tomography studies","volume":"8","author":"Carelli","year":"2017","journal-title":"Front. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/WNO.0000000000000161","article-title":"Optical coherence tomography technologies: Which machine do you want to own?","volume":"34","author":"Costello","year":"2014","journal-title":"J. Neuro-Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/bjophthalmol-2018-312846","article-title":"Ophthalmic manifestations of Gaucher disease: The most common lysosomal storage disorder","volume":"103","author":"Winter","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2013.04.001","article-title":"Retinal thinning in Gaucher disease patients and carriers: Results of a pilot study","volume":"109","author":"McNeill","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5935\/0034-7280.20170066","article-title":"Ophthalmologic findings in Gaucher\u2019s disease type III: Case report","volume":"76","author":"Matos","year":"2017","journal-title":"Rev. Bras. Oftalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/ceo.13476","article-title":"Estimate of the adenosine triphosphate requirement of human retinal ganglion cells","volume":"47","author":"Casson","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1093\/hmg\/ddx273","article-title":"Optic neuropathies: The tip of the neurodegeneration iceberg","volume":"26","author":"Carelli","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.17925\/EOR.2009.03.02.109","article-title":"Retinal Ganglion Cell Life and Death\u2014Mechanisms and Implications for Ophthalmology","volume":"3","author":"Corredor","year":"2009","journal-title":"Eur. Ophthalmic Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00417-011-1745-2","article-title":"A branch retinal artery occlusion in a patient with Gaucher disease","volume":"250","author":"Bruscolini","year":"2012","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jcp.20991","article-title":"Hic-5 Contributes to Transformation Through a RhoA\/ROCK-dependent Pathway","volume":"211","author":"Tumbarello","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.exer.2016.08.006","article-title":"Evaluating retinal ganglion cell loss and dysfunction","volume":"151","author":"Mead","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/eye.2016.295","article-title":"Assessing retinal ganglion cell damage","volume":"31","author":"Smith","year":"2017","journal-title":"Eye"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/revneuro-2013-0003","article-title":"Optic neuropathies: Characteristic features and mechanisms of retinal ganglion cell loss","volume":"24","author":"You","year":"2013","journal-title":"Rev. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bcmd.2016.12.006","article-title":"Classifying the additional morbidities of Gaucher disease","volume":"68","author":"Langeveld","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JPD-171092","article-title":"Glucocerebrosidase Mutations in Parkinson Disease","volume":"7","author":"Desouza","year":"2017","journal-title":"J. Parkinson\u2019s Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in gaucher disease in a non-jewish, caucasian cohort of gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(89)90536-9","article-title":"Prediction of Severity of Gaucher\u2019S Disease By Identification of Mutations At Dna Level","volume":"334","author":"Zimran","year":"1989","journal-title":"Lancet"},{"key":"ref_29","first-page":"1094","article-title":"Phenotype\/genotype correlations in Gaucher disease type 1: Clinical and therapeutic implications","volume":"52","author":"Sibille","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs\u2014An Extension of the Modified Airlie House Classification: ETDRS Report Number 10","volume":"98","author":"Treatment","year":"1991","journal-title":"Ophthalmology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:13:10Z","timestamp":1760177590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":30,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ijms21197027"],"URL":"https:\/\/doi.org\/10.3390\/ijms21197027","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}